Rossari Biotech unit sets up Thailand facility with 5000 MTPA capacity

1 min read Updated on 27 Jun 2026, 04:23 AM

Reviewed by

Naman SScanX News Team

AI Summary

Rossari Biotech's subsidiary Unistar Thai has established a blending facility in Thailand with an installed capacity of 5000 MTPA. The plant, located on ~1,860 square meters, serves as a regional technical hub to address the Southeast Asian market with customized formulations. It offers flexible manufacturing capabilities for powders, granules, and liquids, supported by dedicated storage for raw materials.

*this image is generated using AI for illustrative purposes only.

Rossari Biotech's subsidiary Unistar Thai has established a blending facility in Thailand with an installed capacity of 5000 MTPA. The new plant is situated on a land area of approximately 1,860 square meters and is designed to function as a regional technical hub. This strategic move aims to address the growing Southeast Asian market through customized formulations tailored to local requirements.

The facility offers flexible manufacturing capabilities across powders, granules, and liquids. It is supported by dedicated storage capacity for surfactants and other key raw materials, which ensures supply chain resilience and operational efficiency. The development follows the acquisition of 100% equity share capital of Unistar Thai by Rossari Global FZCO, a wholly owned subsidiary of Rossari Biotech, on December 10, 2024.

Key Details of the New Facility

Feature	Details
Subsidiary	Unistar Thai Co. Limited
Location	Thailand
Installed Capacity	5000 MTPA
Land Area	~1,860 square meter
Manufacturing Capabilities	Powders, granules, liquids

The disclosure was made to the exchanges under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was signed by Parul Gupta, Company Secretary & Head - Legal.

Historical Stock Returns for Rossari Biotech

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.13%	+0.06%	+1.67%	-7.28%	-25.62%	-55.73%

What is the projected timeline for the facility to reach full operational capacity?

How will this expansion impact Rossari Biotech's revenue margins in the upcoming fiscal year?

Are there plans to establish similar technical hubs in other Southeast Asian markets?

Read Next Article

Rossari Biotech to host virtual investor meet on June 12

0 min read Updated on 09 Jun 2026, 01:31 AM

Reviewed by

Naman SScanX News Team

Add as a preferred
source on Google

AI Summary

Rossari Biotech Limited has scheduled a virtual investor and analyst meet for June 12, 2026, at 12:00 PM IST with Kotak PCG Clients. The discussion will be based on the earnings presentation submitted to the stock exchanges on April 28, 2026. The company confirmed that no unpublished price sensitive information will be shared during the event.

*this image is generated using AI for illustrative purposes only.

Rossari Biotech Limited has scheduled a virtual investor and analyst meet for June 12, 2026, to discuss its financial performance. The meeting will be conducted via a virtual conference at 12:00 PM IST and will include a group session with Kotak PCG Clients. The discussions will be based on financial and other information already available to the public, specifically referencing the earnings presentation submitted to the stock exchanges on April 28, 2026.

The company stated that the timing of the event is subject to change due to exigencies on the part of investors or the company. Rossari Biotech clarified that no unpublished price sensitive information will be shared during the meeting. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.